| Overview |
| bsm-51697M |
| PSMC2 Monoclonal Antibody |
| WB |
| Human, Mouse, Cow |
| Specifications |
| Unconjugated |
| Mouse |
| Recombinant human PSMC2. |
| Monoclonal |
| G5K1 |
| 0.5ug/ul |
| 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| 5701 |
| P35998 |
| Cytoplasm, Nucleus |
| 26S protease regulatory subunit 7; PRS7_HUMAN; 26S protease complex; 26S proteasome AAA-ATPase subunit RPT1; mammalian suppressor of sgv-1 of yeast; MSS1; Nbla10058; protease 26S subunit 7; proteasome 26S ATPase subunit 2; Proteasome 26S subunit ATPase 2; proteasome 26S subunit ATPase 2; Protein MSS1; putative protein product of Nbla10058; S7 antibody. |
| The 26S protease is involved in the ATP-dependent degradation of ubiquitinated proteins. The regulatory (or ATPase) complex confers ATP dependency and substrate specificity to the 26S complex. In case of HIV-1 infection, positive modulator of Tat-mediated transactivation. |
| Application Dilution |
| WB |
=1:500-2000， |
Powered by Bioz